Publications by authors named "Ken Redekop"

Claim this Profile
E
ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics.
Erik H M Kemper, Hendrik Erenstein, Bart-Jan Boverhof, Ken Redekop, Anna E Andreychenko

Eur Radiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 inhibitor experiences and preferences of patients and healthcare professionals in decision-making: A mixed methods study.
Janneke W C M Mulder, Annette M H Galema-Boers, Leonieke W Kranenburg, Ken Redekop, Jeanine E Roeters van Lennep

Atherosclerosis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of remote monitoring of patients with an implantable cardiac defibrillator (REMOTE-CIED study).
Gimon de Graaf, Ivy Timmermans, Mathias Meine, Marco Alings, Susanne S Pedersen, Ken Redekop

J Telemed Telecare· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiology AI Deployment and Assessment Rubric (RADAR) to bring value-based AI into radiological practice.
Bart-Jan Boverhof, W Ken Redekop, Daniel Bos, Martijn P A Starmans, Judy Birch

Insights Imaging· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom.
Jan-Willem Versteeg, Nicolas Jamet, Ken Redekop

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attribution of value for combination immune checkpoint inhibitors in non-small cell lung cancer.
Remziye Zaim, Ken Redekop, Carin A Uyl-de Groot

J Cancer Policy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment.
Remziye Zaim, W Ken Redekop, Carin A Uyl-de Groot

Front Health Serv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer.
Remziye Zaim, W Ken Redekop, Carin A Uyl-de Groot

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2).
Thomas J P Mangnus, Maaike Dirckx, Krishna D Bharwani, Sara J Baart, Theodora A M Siepman, Ken Redekop

BMC Musculoskelet Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: A comparison of the regulatory approvals in Europe and the United States.
Remziye Zaim, Ken Redekop, Carin A Uyl-de Groot

J Cancer Policy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer.
Remziye Zaim, Ken Redekop, Carin A Uyl-de Groot

Transl Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gray Literature in Evaluating Effectiveness in Digital Health and Health and Welfare Technology: A Source Worth Considering.
Sara Landerdahl Stridsberg, Matt X Richardson, Ken Redekop, Maria Ehn, Sarah Wamala Andersson

J Med Internet Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can we discover the most valuable types of big data and artificial intelligence-based solutions? A methodology for the efficient development of the underlying analytics that improve care.
Lytske Bakker, Jos Aarts, Carin Uyl-de Groot, Ken Redekop

BMC Med Inform Decis Mak· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effects of Dexmedetomidine versus Propofol During the Implantation of a Neurostimulator-A Post-Trial Follow-Up Analysis.
Feline F J A Ter Bruggen, W Ken Redekop, Dirk L Stronks, Frank J P M Huygen

J Pain Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile Safety Alarms Based on GPS Technology in the Care of Older Adults: Systematic Review of Evidence Based on a General Evidence Framework for Digital Health Technologies.
Maria Ehn, Matt X Richardson, Sara Landerdahl Stridsberg, Ken Redekop, Sarah Wamala-Andersson

J Med Internet Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium.
Ana Dubon Garcia, Roland Devlieger, Ken Redekop, Katleen Vandeweyer, Stefan Verlohren

Pregnancy Hypertens· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocturnal digital surveillance in aged populations and its effects on health, welfare and social care provision: a systematic review.
Matt X Richardson, Maria Ehn, Sara Landerdahl Stridsberg, Ken Redekop, Sarah Wamala-Andersson

BMC Health Serv Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Cost-Effectiveness Studies of Interventions With a Personalized Nutrition Component in Adults.
Milanne M J Galekop, Carin A Uyl-de Groot, W Ken Redekop

Value Health· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future of Data Analytics in the Era of the General Data Protection Regulation in Europe.
Katarzyna Kolasa, W Ken Redekop, Alexander Berler, Vladimir Zah, Carl V Asche

Pharmacoeconomics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
Anne-Claire Peultier, Ankur Pandya, Richa Sharma, Johan L Severens, W Ken Redekop

JAMA Netw Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trusted writing in social media: FPM International Awards for Medical Writing in Social Media.
Donald Singer, Ken Redekop, Bernard Cheung

Postgrad Med J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is ahead for health policy and technology in the 2020s?
Donald R J Singer, Ken Redekop

Health Policy Technol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trusted writing in social media: FPM International Awards for Medical Writing in Social Media.
Donald Rj Singer, Ken Redekop, Bernard Cheung

Health Policy Technol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
Amir Ansaripour, Kazem Zendehdel, Niki Tadayon, Fatemeh Sadeghi, Carin A Uyl-de Groot, W Ken Redekop

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
Amir Ansaripour, Carin A Uyl-de Groot, W Ken Redekop

Pharmacoeconomics· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis